Join

Compare · LPL vs TMO

LPL vs TMO

Side-by-side comparison of LG Display Co Ltd (LPL) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • LPL operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
  • TMO is the larger of the two at $225.41B, about 38.6x LPL ($5.85B).
  • TMO has been more active in the news (6 items in the past 4 weeks vs 2 for LPL).
  • TMO has more recent analyst coverage (25 ratings vs 16 for LPL).
MetricLPLTMO
Company
LG Display Co Ltd
Thermo Fisher Scientific Inc
Price
$4.17-2.23%
$469.57+0.63%
Market cap
$5.85B
$225.41B
1M return
-
-4.31%
1Y return
-
+11.45%
Industry
Industrial Machinery/Components
Industrial Machinery/Components
Exchange
NYSE
NYSE
IPO
2004
News (4w)
2
6
Recent ratings
16
25
LPL

LG Display Co Ltd

LG Display Co., Ltd. engages in the design, manufacture, and sale of thin-film transistor liquid crystal display (TFT-LCD) and organic light emitting diode (OLED) technology-based display panels. Its TFT-LCD and OLED technology-based display panels are primarily used in televisions, notebook computers, desktop monitors, tablet computers, mobile devices, and automotive displays. The company also provides display panels for industrial and other applications, including entertainment systems, portable navigation devices, and medical diagnostic equipment. It operates in South Korea, China, rest of Asia, the United States, Poland, and other European countries. The company was formerly known as LG.Philips LCD Co., Ltd. and changed its name to LG Display Co., Ltd. in March 2008. LG Display Co., Ltd. was incorporated in 1985 and is headquartered in Seoul, South Korea.

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.